MCP-1 22518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5413-5419

  Ben Selma, Walid ^a   Harizi, Hedi ^b   Boukadida, Jalel ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b CNRS Bordeaux Segalen University   (France)

Author keywords

MCP 1; Polymorphism; Susceptibility; Tuberculosis

Indexed keywords

GENOMIC DNA; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE CHEMOATTRACTANT PROTEIN 1 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA; CASE CONTROL STUDY; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS, PULMONARY; TUNISIA; YOUNG ADULT;

EID: 84855238339     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0695-4     Document Type: Article

References (53)

1. Van Coillie E, Van Damme J, Opdenakker G (1999) The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 10:61-86 (Pubitemid 29230852)
2. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259(2):338-344
3. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montaño M, Barnes PF, Selman M, Granados J (2005) A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 202(12):1649-1658 (Pubitemid 41815871)
4. Holla LI, Mrazek F, Petrek M (2009) MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders. Int J Immunogenet 36(1):69-72
5. Ahad MA, Missotten T, Abdallah A, Lympany PA, Lightman S (2007) Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol Vis 13:388-396 (Pubitemid 46477707)
6. Karaali ZE, Sozen S, Yurdum M, Cacina C, Toptas B, Gok O, Agachan B (2010) Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep 7:3615-3619
7. Kruszyna L, Lianeri M, Rubis B, Knuła H, Rybczyńska M, Grodecka-Gazdecka S, Jagodziński PP (2011) CCL2-2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Mol Biol Rep 38(2):1263-1267
8. Kouyama K, Miyake K, Zenibayashi M, Hirota Y, Teranishi T, Tamori Y, Kanda H, Sakaguchi K, Ohara T, Kasuga M (2008) Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. Kobe J Med Sci 53(6):345-354 (Pubitemid 351872375)
9. Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Müller NG, Cavalcanti VL, Ianni B, Mady C, Kalil J, Goldberg AC (2006) The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis 43(3):305-311 (Pubitemid 44078901)
10. Ganachari M, Ruiz-Morales JA, Gomez de la Torre Pretell JC, Dinh J, Granados J, Flores-Villanueva PO (2010) Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vacci-nated individuals. PLoS One 5(1):e8881
11. Saunders BM, Britton WJ (2007) Life and death in the granu-loma: immunopathology of tuberculosis. Immunol Cell Biol 85:103-111 (Pubitemid 46398725)
12. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD (2001) Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 98(14):7958-7963 (Pubitemid 32642669)
13. Peters W, Cyster JG, Mack M, Schlöndorff D, Wolf AJ, Ernst JD, Charo IF (2004) CCR2-dependent trafficking of F4/80dim mac-rophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J Immunol 172(12):7647-7653 (Pubitemid 38747630)
14. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552-2561 (Pubitemid 27514895)
15. Fietta A, Meloni F, Francioli C, Morosini M, Bulgheroni A, Casali L, Gialdroni Grassi G (2001) Virulence of Mycobacterium tuberculosis affects interleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes. Int J Tissue React 23:113-125 (Pubitemid 33121152)
16. Kurashima K, Mukaida N, Fujimura M, Yasui M, Nakazumi Y, Matsuda T, Matsushima K (1997) Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 155:1474-1477 (Pubitemid 27172801)
17. Lin Y, Gong J, Zhang M, Xue W, Barnes PF (1998) Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun 66:2319-2322 (Pubitemid 28194136)
18. World Health Organization (2008) Tuberculosis. WHO report 2008, Geneva, Switzerland: WHO (2008). http://www.who.int/GlobalAtlas/predefinedReports/TB/ PDF-Files/tun.pdf. Accessed Nov 2010
19. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20:581-620 (Pubitemid 34293435)
20. Bellamy R (2003) Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 4:4-11 (Pubitemid 38967569)
21. Delgado JC, Baena A, Thim S, Goldfeld AE (2002) Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 186:1463-1468 (Pubitemid 35286114)
22. López-Maderuelo D, Arnalich F, Serantes R, González A, Cod-oceo R, Madero R, Vázquez JJ, Montiel C (2003) Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167:970-975 (Pubitemid 36408162)
23. Amim LH, Pacheco AG, Fonseca-Costa J, Loredo CS, Rabahi MF, Melo MH, Ribeiro FC, Mello FC, Oliveira MM, Lapa e Silva JR, Ottenhoff TH, Kritski AL, Santos AR (2008) Role of IFN-c + 874 T/A single nucleotide polymorphism in the tuberculosis outcome among Brazilians subjects. Mol Biol Rep 35:563-566
24. Vallinoto AC, Graça ES, Araújo MS, Azevedo VN, Cayres-Vallinoto I, Machado LF, Ishak MO, Ishak R (2010) IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum Immunol 71:692-696
25. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Na-kamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96:4581-4585 (Pubitemid 29190379)
26. Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, Freidhoff LR, Sengler C, Plitt JR, Schleimer RP, Caraballo L, Naidu RP, Levett PN, Beaty TH, Huang SK (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164:1612-1616 (Pubitemid 30067281)
27. World Health Organization (2010) WHO report 2010. http://www. emro.who.int/stb/pdf/CountryProfile-tun-08.pdf. Accessed 18 Jan 2010
28. American Thoracic Society (2000) Diagnostic standards, classification of tuberculosis in adults, children. Am J Respir Crit Care Med 161:1376-1395
29. Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518G/G genotype in CAD patients. Atherosclerosis 158:233-239 (Pubitemid 32735489)
30. Rodriguez S, Gaunt TR, Day IN (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505-514
31. Barnes DS (2000) Historical perspectives on the etiology of tuberculosis. Microbes Infect 2:431-440
32. Cooke GS, Hill AV (2001) Genetics of susceptibility to human infectious disease. Nat Rev Genet 2:967-977 (Pubitemid 33691093)
33. Möller M, Hoal EG (2010) Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 90:71-83
34. Ates O, Dolek B, Dalyan L, Musellim B, Ongen G, Topal-Sari-kaya A (2010) The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis. Mol Biol Rep. doi: 10.1007/s11033-010-0404-8
35. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R (2005) Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol 6:14
36. Kipnis A, Basaraba R, Orme I, Cooper A (2003) Role of che-mokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 109:547-551 (Pubitemid 36930170)
37. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61(9):863-866
38. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369-1376 (Pubitemid 28467565)
39. Yilmaz V, Yentur SP, Saruhan-Direskeneli G (2005) IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 30(4):188-194 (Pubitemid 40615967)
40. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G (2002) A TaqI polymorphism in the 30UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3(7):419-423 (Pubitemid 41656541)
41. Ma X, Reich RA, Gonzalez O, Pan X, Fothergill AK, Starke JR, Teeter LD, Musser JM, Graviss EA (2003) No evidence for association between the polymorphism in the 30 untranslated region of interleukin-12B and human susceptibility to tuberculosis. J Infect Dis 88(8):1116-1118 (Pubitemid 37338974)
42. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK (2004) Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 190(5):913-919 (Pubitemid 39120968)
43. Morahan G, Kaur G, Singh M, Rapthap CC, Kumar N, Katoch K, Mehra NK, Huang D (2007) Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 69(Suppl. 1):234-236 (Pubitemid 46625891)
44. Henao MI, Montes C, Paris SC, Garcia LF (2006) Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis 86(1):11-19 (Pubitemid 41797654)
45. Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV (2006) Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 174(3):339-343 (Pubitemid 44156614)
46. Oral HB, Budak F, Uzaslan EK, Baştürk B, Bekar A, Akalin H, Ege E, Ener B, Göral G (2006) Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 35(3-4):143-147 (Pubitemid 44666429)
47. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ (1995) High level monocyte chemoat-tractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155:4838-4843
48. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM (1995) The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84(3): 423-432
49. Cooper AM, Magram J, Ferrante J, Orme IM (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186(1):39-45 (Pubitemid 27304845)
50. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, de Sauvage F, Cooper AM (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen specific IFN-gamma responses if IL-12p70 is available. J Immunol 175:788-795 (Pubitemid 41094960)
51. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM, Shaw MA, Burgner D, Xu W, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 5:46-57 (Pubitemid 38967629)
52. Chu SF, Tam CM, Wong HS, Kam KM, Lau YL, Chiang AK (2007) Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 8:475-479 (Pubitemid 47365613)
53. Möller M, Nebel A, Valentonyte R, van Helden PD, Schreiber S, Hoal EG (2009) Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberculosis 89:189-194